Health Canada Grants Adastra Labs Its Cannabis Processing Licence
Adastra Labs Holdings Ltd., a provider of same site cannabis extraction and analytical testing services, is pleased to announce its subsidiary Adastra Labs Inc. has been issued a standard processing licence under the cannabis regulationsby Health Canada.
The standard processing licence received by Adastra will be valid for three years and authorizes Adastra to conduct cannabis processing activities at the company’s newly renovated GMP-compliant 13,000 square foot facility, located in Langley, British Columbia, which is shared by subsidiary Chemia Analytics Inc., a Health Canada licensed analytical testing laboratory.
“I am very proud of the Adastra team for achieving this critical milestone in our business plan. We are eager to get started in refining and optimizing our cannabis processing operations as soon as possible,” stated Andy Hale, Adastra’s CEO.
Under the terms of its standard processing licence, Adastra will be able to possess cannabis, produce cannabis, by means other than cultivating it, and to sell cannabis in accordance with the cannabis regulations.The issuance of a standard processor licence will permit Adastra to execute its business plan and produce cannabis extract products and formulations.
Upon the commencement of formal operations, Adastra will be initially capable of processing approximately 10,000 grams of dried cannabis every hour into cannabis extracts. Its process will create high-value cannabis extracts by supercritical CO2 extraction and secondary distillation that will be easily incorporated into a variety of value-added products such as, edibles, beverages, topicals, tinctures, and vape cartridges that will serve the Canadian recreational and medicinal cannabis markets.
This article has been republished from material provided by Adastra Labs Holdings Ltd. Note: material may have been edited for length and content. For further information, please contact the cited source.